[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4794 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
2d Session
S. 4794
To amend the Public Health Service Act with respect to opioid overdose
reversal medication access, education, and co-prescribing grant
programs, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 7, 2022
Ms. Baldwin introduced the following bill; which was read twice and
referred to the Committee on Health, Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To amend the Public Health Service Act with respect to opioid overdose
reversal medication access, education, and co-prescribing grant
programs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Naloxone Education and Access Act''.
SEC. 2. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS, EDUCATION, AND CO-
PRESCRIBING GRANT PROGRAMS.
Section 545 of the Public Health Service Act (42 U.S.C. 290ee) is
amended--
(1) in the section heading, by striking ``access and
education'' and inserting ``access, education, and co-
prescribing'';
(2) in subsection (a)--
(A) in the subsection heading, by striking ``to
states'';
(B) in the matter preceding paragraph (1), by
striking ``States'' and inserting ``eligible
entities'';
(C) in paragraph (1), by striking ``for pharmacists
to dispense a drug or device approved or cleared'' and
inserting ``that increase access to drugs and devices
approved, cleared, or otherwise legally marketed'';
(D) by redesignating paragraphs (3) and (4) as
paragraphs (5) and (6), respectively;
(E) by inserting after paragraph (2) the following:
``(3) encourage health care providers to co-prescribe, as
appropriate, drugs or devices approved, cleared, or otherwise
legally marketed under the Federal Food, Drug, and Cosmetic Act
for emergency treatment of known or suspected opioid overdose;
``(4) support innovative community-based distribution
programs of drugs or devices approved, cleared, or otherwise
legally marketed under the Federal Food, Drug, and Cosmetic Act
for emergency treatment of known or suspected opioid
overdose;'';
(F) in paragraphs (5) and (6), as so redesignated,
by striking ``approved or cleared'' each place it
appears and inserting ``approved, cleared, or otherwise
legally marketed'';
(3) in subsection (b)--
(A) by striking ``State'' and inserting ``eligible
entity''; and
(B) by striking ``approved or cleared'' and
inserting ``approved, cleared, or otherwise legally
marketed'';
(4) in subsection (c)--
(A) in the matter preceding paragraph (1), by
striking ``States'' and inserting ``eligible
entities''; and
(B) by striking ``approved or cleared'' each place
it appears and inserting ``approved, cleared, or
otherwise legally marketed'';
(5) in subsection (d)--
(A) in paragraph (1), by striking ``A State'' and
inserting ``An eligible entity'';
(B) in paragraph (2), by striking ``3'' and
inserting ``5''; and
(C) by amending paragraph (3) to read as follows:
``(3) Limitation.--An eligible entity may use--
``(A) not more than 10 percent of a grant under
this section for educating the public pursuant to
subsection (a)(6); and
``(B) not less than 20 percent of a grant under
this section to offset cost-sharing for distribution
and dispensing of drugs or devices approved, cleared,
or otherwise legally marketed under the Federal Food,
Drug, and Cosmetic Act for emergency treatment of known
or suspected opioid overdose.'';
(6) in subsection (e), by striking ``a State'' and
inserting ``an eligible entity'';
(7) in subsection (f)--
(A) by striking ``A State'' and inserting ``An
eligible entity'';
(B) by striking ``in the State'' and inserting ``in
the jurisdiction of the eligible entity''; and
(C) by striking ``approved or cleared'' and
inserting ``approved, cleared, or otherwise legally
marketed'';
(8) by amending subsection (g) to read as follows:
``(g) Definitions.--In this section:
``(1) Eligible entity.--The term `eligible entity' means a
State, locality, Indian Tribe, Tribal organization, or Urban
Indian organization.
``(2) Indian tribe.--The term `Indian Tribe' has the
meaning given the term in section 4 of the Indian Self-
Determination and Education Assistance Act.
``(3) Standing order.--The term `standing order' means a
document prepared by a person authorized to prescribe
medication that permits another person to acquire, dispense, or
administer medication without a person-specific prescription.
``(4) Tribal organization.--The term `Tribal organization'
has the meaning given the term in section 4 of the Indian Self-
Determination and Education Assistance Act.
``(5) Urban indian organization.--The term `Urban Indian
organization' has the meaning given the term in section 4 of
the Indian Health Care Improvement Act.''; and
(9) in subsection (h)(1)--
(A) by striking ``$5,000,000'' and inserting
``$10,000,000''; and
(B) by striking ``2017 through 2019'' and inserting
``2023 through 2027''.
<all>